Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Shares Issued (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Shares Issued data on record, last reported at -$31000.0 in Q4 2021.

  • For Q4 2021, Shares Issued rose 99.69% year-over-year to -$31000.0; the TTM value through Dec 2021 reached $443000.0, down 13.48%, while the annual FY2025 figure was $1.3 million, 578.39% up from the prior year.
  • Shares Issued reached -$31000.0 in Q4 2021 per COGT's latest filing, up from -$10.2 million in the prior quarter.
  • Across five years, Shares Issued topped out at $61.8 million in Q4 2018 and bottomed at -$56.5 million in Q2 2018.
  • Average Shares Issued over 4 years is $591000.0, with a median of $33000.0 recorded in 2018.
  • Peak YoY movement for Shares Issued: crashed 60.71% in 2019, then skyrocketed 245.45% in 2020.
  • A 4-year view of Shares Issued shows it stood at $61.8 million in 2018, then plummeted by 99.84% to $97000.0 in 2019, then crashed by 10572.16% to -$10.2 million in 2020, then soared by 99.69% to -$31000.0 in 2021.
  • Per Business Quant database, its latest 3 readings for Shares Issued were -$31000.0 in Q4 2021, -$10.2 million in Q4 2020, and $10.6 million in Q3 2020.